Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer

Abstract excerpt

Although histological and molecular classifications have been extensively studied for gastric cancer (GC), targeted therapies for GC remain limited. CDH1 mutations (MT) are characteristic of genomically stable GC and are associated with poor prognosis, but lack effective or targeted therapies. Here, we showed the overall mutation frequency of CDH1 was 9.7% (155 of 1596). CDH1-MT GC showed significantly lower...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer-related gene regulation
• Share to Chromatin Remodeling and Cancer
• Share to Peptidase Inhibition and Analysis